EP3773686 - ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.04.2024 Database last updated on 09.09.2024 | |
Former | The patent has been granted Status updated on 05.05.2023 | ||
Former | Grant of patent is intended Status updated on 13.03.2023 | ||
Former | Request for examination was made Status updated on 15.01.2021 | ||
Former | The international publication has been made Status updated on 28.09.2019 | Most recent event Tooltip | 24.05.2024 | Lapse of the patent in a contracting state New state(s): IT | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states Theriva Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | [2023/23] |
Former [2021/07] | For all designated states Synthetic Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | Inventor(s) | 01 /
KALEKO, Michael c/o Synthetic Biologics, Inc. 9605 Medical Center Drive, Suite 270 Rockville, MD 20850 / US | 02 /
FURLAN FREGUIA, Christian c/o Synthetic Biologics, Inc. 9605 Medical Center Drive, Suite 270 Rockville, MD 20850 / US | 03 /
CONNELLY, Sheila c/o Synthetic Biologics, Inc. 9605 Medical Center Drive, Suite 270 Rockville, MD 20850 / US | [2021/07] | Representative(s) | Boxall, Sarah Jane Boxall IPM Ltd 9 King Street Sandwich Kent CT13 9BT / GB | [2021/07] | Application number, filing date | 19770253.3 | 20.03.2019 | [2021/07] | WO2019US23143 | Priority number, date | US201862645469P | 20.03.2018 Original published format: US 201862645469 P | US201862714398P | 03.08.2018 Original published format: US 201862714398 P | [2021/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019183209 | Date: | 26.09.2019 | Language: | EN | [2019/39] | Type: | A1 Application with search report | No.: | EP3773686 | Date: | 17.02.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application. | [2021/07] | Type: | B1 Patent specification | No.: | EP3773686 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Search report(s) | International search report - published on: | US | 26.09.2019 | (Supplementary) European search report - dispatched on: | EP | 23.11.2021 | Classification | IPC: | A61K38/46, A61K45/06, A61P39/00 | [2021/51] | CPC: |
A61K45/06 (EP);
A61K38/465 (EP,US);
A61K35/74 (EP);
A61K9/0053 (US);
A61P1/00 (EP);
A61P39/00 (EP,US);
C12Y301/03001 (US)
(-)
| C-Set: |
A61K35/74, A61K2300/00 (EP);
A61K38/465, A61K2300/00 (EP) |
Former IPC [2021/07] | A61K38/46, A61K45/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ALKALISCHE PHOSPHATASEMITTEL ZUR BEHANDLUNG VON BESTRAHLUNGSSTÖRUNGEN | [2021/07] | English: | ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS | [2021/07] | French: | AGENTS AU PHOSPHATASE ALCALINE POUR LE TRAITEMENT DE TROUBLES DUS À UNE EXPOSITION À DES RADIATIONS | [2021/07] | Entry into regional phase | 14.10.2020 | National basic fee paid | 14.10.2020 | Search fee paid | 14.10.2020 | Designation fee(s) paid | 14.10.2020 | Examination fee paid | Examination procedure | 14.10.2020 | Examination requested [2021/07] | 09.06.2022 | Amendment by applicant (claims and/or description) | 13.03.2023 | Communication of intention to grant the patent | 25.04.2023 | Fee for grant paid | 25.04.2023 | Fee for publishing/printing paid | 25.04.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP23177425.8 / EP4275761 | Opposition(s) | 08.03.2024 | No opposition filed within time limit [2024/20] | Fees paid | Renewal fee | 18.03.2021 | Renewal fee patent year 03 | 17.03.2022 | Renewal fee patent year 04 | 07.03.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 07.06.2023 | CZ | 07.06.2023 | DK | 07.06.2023 | EE | 07.06.2023 | ES | 07.06.2023 | FI | 07.06.2023 | HR | 07.06.2023 | IT | 07.06.2023 | LT | 07.06.2023 | LV | 07.06.2023 | NL | 07.06.2023 | PL | 07.06.2023 | RO | 07.06.2023 | RS | 07.06.2023 | SE | 07.06.2023 | SI | 07.06.2023 | SK | 07.06.2023 | SM | 07.06.2023 | NO | 07.09.2023 | GR | 08.09.2023 | IS | 07.10.2023 | PT | 09.10.2023 | [2024/26] |
Former [2024/25] | AT | 07.06.2023 | |
CZ | 07.06.2023 | ||
DK | 07.06.2023 | ||
EE | 07.06.2023 | ||
ES | 07.06.2023 | ||
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
PL | 07.06.2023 | ||
RO | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
SI | 07.06.2023 | ||
SK | 07.06.2023 | ||
SM | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
IS | 07.10.2023 | ||
PT | 09.10.2023 | ||
Former [2024/22] | AT | 07.06.2023 | |
CZ | 07.06.2023 | ||
DK | 07.06.2023 | ||
EE | 07.06.2023 | ||
ES | 07.06.2023 | ||
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
PL | 07.06.2023 | ||
RO | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
SK | 07.06.2023 | ||
SM | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
IS | 07.10.2023 | ||
PT | 09.10.2023 | ||
Former [2024/10] | AT | 07.06.2023 | |
CZ | 07.06.2023 | ||
EE | 07.06.2023 | ||
ES | 07.06.2023 | ||
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
PL | 07.06.2023 | ||
RO | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
SK | 07.06.2023 | ||
SM | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
IS | 07.10.2023 | ||
PT | 09.10.2023 | ||
Former [2024/09] | AT | 07.06.2023 | |
CZ | 07.06.2023 | ||
ES | 07.06.2023 | ||
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
SK | 07.06.2023 | ||
SM | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
IS | 07.10.2023 | ||
Former [2024/08] | ES | 07.06.2023 | |
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
SK | 07.06.2023 | ||
SM | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2024/03] | ES | 07.06.2023 | |
FI | 07.06.2023 | ||
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2024/01] | ES | 07.06.2023 | |
HR | 07.06.2023 | ||
LT | 07.06.2023 | ||
LV | 07.06.2023 | ||
NL | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2023/52] | ES | 07.06.2023 | |
HR | 07.06.2023 | ||
NL | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2023/51] | ES | 07.06.2023 | |
HR | 07.06.2023 | ||
RS | 07.06.2023 | ||
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2023/50] | ES | 07.06.2023 | |
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
GR | 08.09.2023 | ||
Former [2023/48] | ES | 07.06.2023 | |
SE | 07.06.2023 | ||
NO | 07.09.2023 | ||
Former [2023/46] | ES | 07.06.2023 | Documents cited: | Search | [X]WO2007032818 (ZOLTAN LAB LLC [US], et al) [X] 12-15 * paragraph [0004] - paragraph [0009]; example 32; claim 21; table 7 ** paragraph [0033] *; | [A] - RENTEA REBECCA M ET AL, "Radiation-induced changes in intestinal and tissue-nonspecific alkaline phosphatase: implications for recovery after radiation therapy", AMERICAN JOURNAL OF SURGERY, PAUL HOEBER, NEW YORK, NY, US, (20160718), vol. 212, no. 4, doi:10.1016/J.AMJSURG.2016.06.005, ISSN 0002-9610, pages 602 - 608, XP029761276 [A] 1-11 * abstract * * page 605; figures 1A-D * DOI: http://dx.doi.org/10.1016/j.amjsurg.2016.06.005 | International search | [Y]US2010158888 (KISS ZOLTAN [US]) [Y] 33-34* para [0086] *; | [XY]US2011052560 (BRANDS RUDI [NL]) [X] 31 * Abstract; Claim 16; Claim 17; para [0008]; para [0026]; para [0058] * [Y] 1-9, 32-34; | [Y]JP2017192381 (TOSOH CORP) [Y] 4, 9/4, 32 * para [0007]; para [0021]; SEQ ID NO:1 *; | [Y] - HAUER-JENSEN et al., "Radiation enteropathy--pathogenesis, treatment and prevention", Nat Rev Gastroenterol Hepatol., (20140800), vol. 11, no. 8, pages 470 - 479, XP055640559 [Y] 1-9 * . AOP, pp 1-10. (p1, col 2, last para-p2, col 1, para 1; p2, col 1, box 1; p2, col 2, para 3; p8, col 2, box * DOI: http://dx.doi.org/10.1038/nrgastro.2014.46 |